Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cell therapy product administration and safety: data capture and analysis from the Production Assistance for Cellular Therapies (PACT) program.

× No keyword cloud information.

23 in total

Review 1. Inflammatory bowel disease: Moving toward a stem cell-based therapy.

Authors: Giacomo Lanzoni; Giulia Roda; Andrea Belluzzi; Enrico Roda; Gian Paolo Bagnara
Journal: World J Gastroenterol Date: 2008-08-07 Impact factor: 5.742

2. Cell therapy: cGMP facilities and manufacturing.

Authors: Raffaella Giancola; Tiziana Bonfini; Antonio Iacone
Journal: Muscles Ligaments Tendons J Date: 2012-10-16

Review 3. Regulatory T-cell therapy in transplantation: moving to the clinic.

Authors: Qizhi Tang; Jeffrey A Bluestone
Journal: Cold Spring Harb Perspect Med Date: 2013-11-01 Impact factor: 6.915

4. An update from the United States National Heart, Lung, and Blood Institute-funded Production Assistance for Cellular Therapies (PACT) program: a decade of cell therapy.

Authors: Deborah Wood; Robin Wesselschmidt; Peiman Hematti; Adrian P Gee; Cliona Rooney; Leslie Silberstein; Myriam Armant; Larry Couture; John E Wagner; David H McKenna; Derek Hei; Traci Heath Mondoro; Lisbeth Welniak; Robert Lindblad
Journal: Clin Transl Sci Date: 2014-03-21 Impact factor: 4.689

Review 5. Stem cell therapy for retinal disease.

Authors: Michael D Tibbetts; Michael A Samuel; Tom S Chang; Allen C Ho
Journal: Curr Opin Ophthalmol Date: 2012-05 Impact factor: 3.761

6. NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction.

Authors: Jeffrey S Miller; Edus H Warren; Marcel R M van den Brink; Jerome Ritz; Warren D Shlomchik; William J Murphy; A John Barrett; Hans Jochem Kolb; Sergio Giralt; Michael R Bishop; Bruce R Blazar; J H Frederik Falkenburg
Journal: Biol Blood Marrow Transplant Date: 2010-02-10 Impact factor: 5.742

7. Good manufacturing practices production of natural killer cells for immunotherapy: a six-year single-institution experience.

Authors: David H McKenna; Darin Sumstad; Nancy Bostrom; Diane M Kadidlo; Susan Fautsch; Sarah McNearney; Rose Dewaard; Philip B McGlave; Daniel J Weisdorf; John E Wagner; Jeffrey McCullough; Jeffrey S Miller
Journal: Transfusion Date: 2007-03 Impact factor: 3.157

Review 8. Cell-based interventions to halt autoimmunity in type 1 diabetes mellitus.

Authors: A E Barcala Tabarrozzi; C N Castro; R A Dewey; M C Sogayar; L Labriola; M J Perone
Journal: Clin Exp Immunol Date: 2013-02 Impact factor: 4.330

Review 9. Moving to tolerance: clinical application of T regulatory cells.

Authors: Alicia N McMurchy; Andrew Bushell; Megan K Levings; Kathryn J Wood
Journal: Semin Immunol Date: 2011-05-28 Impact factor: 11.130

Review 10. New perspectives in human stem cell therapeutic research.

Authors: Alan Trounson
Journal: BMC Med Date: 2009-06-11 Impact factor: 8.775

1 in total

1. Cardiopulmonary and histological characterization of an acute rat lung injury model demonstrating safety of mesenchymal stromal cell infusion.

Authors: Rudolf K Braun; Jill M Koch; Timothy A Hacker; David Pegelow; Jaehyup Kim; Amish N Raval; Eric G Schmuck; Denise J Schwahn; Derek J Hei; John M Centanni; Marlowe Eldridge; Peiman Hematti
Journal: Cytotherapy Date: 2016-04 Impact factor: 5.414

1 in total